NCT03631342

Brief Summary

The hyperinflation ventilator was performed in different modalities and ventilatory adjustments, with total pressure of 40cmH2O. The inspiratory volume, inspiratory time, mean airway pressure, inspiratory and expiratory flow, and bias flow were evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 18, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2017

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 6, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 15, 2018

Completed
Last Updated

August 15, 2018

Status Verified

August 1, 2018

Enrollment Period

7 months

First QC Date

August 6, 2018

Last Update Submit

August 13, 2018

Conditions

Keywords

Ventilator HyperinflationPhysical TherapyMechanical Ventilation

Outcome Measures

Primary Outcomes (7)

  • Inspiratory Volume

    Inspiratory volume reached in each mode of ventilator hyperinflation, under a maximum pressure of 40cmH2O

    Five minutes after the onset of intervention

  • Inspiratory time

    inspiratory time necessary for the inspiratory flow to reach the baseline or according to the settings of each modality

    Five minutes after the onset of intervention

  • Mean Pressure

    airway mean pressure measured on the mechanical ventilator in 2 cycles

    Five minutes after the onset of intervention

  • Peak Expiratory Flow

    maximal expiratory flow in 2 cycles

    Five minutes after the onset of intervention

  • Peak Inspiratory Flow

    Maximal inspiratory flow in 2 cycles

    Five minutes after the onset of intervention

  • PIFR/PEFR

    Peak inspiratory to expiratory flow ratio

    Five minutes after the onset of intervention

  • Bias Flow

    Difference between peak inspiratory and expiratory flows

    Five minutes after the onset of intervention

Study Arms (5)

VCV20

EXPERIMENTAL

Volume-controlled ventilation mode under constant flow of 20 Lpm. The inspired volume was progressively increased until the maximum pressure reached 40cmH2O.

Other: VCV20

VCV40

EXPERIMENTAL

Volume controlled ventilation mode under constant flow of 40 Lpm. The inspired volume was progressively increased until the maximum pressure reached 40cmH2O.

Other: VCV40

PCV

EXPERIMENTAL

Pressure controlled ventilation mode, inspiratory time of 1 second. The inspiratory pressure was increased every 5 cmH2O, until reaching the maximum pressure of 40 cmH2O.

Other: PCV

PCV+Tins

EXPERIMENTAL

Pressure controlled ventilation mode and inspiratory pressure was increased every 5cmH2O, until the maximum pressure of 40 cmH2O was reached. The inspiratory time was gradually increased until the inspiratory flow reached the baseline. Concomitantly, the respiratory rate was decreased to allow the expiratory flow also to reach the baseline, to avoid self-PEEP.

Other: PCV+Tins

PSV

EXPERIMENTAL

Pressure support ventilation mode, with progressive increases of 5 cmH2O at inspiratory pressure, until reaching Pmax of 40 cmH2O. The expiratory sensitivity was adjusted by 25% for all patients.

Other: PSV

Interventions

VCV20OTHER

controlled volume ventilation mode under constant flow of 20 Lpm. The inspired volume was progressively increased until the Pmax reached 40cmH2O.

VCV20
VCV40OTHER

volume controlled ventilation mode under constant flow of 40 Lpm. The inspired volume was progressively increased until the Pmax reached 40cmH2O.

VCV40
PCVOTHER

controlled ventilation mode, 1 second inspiratory time. The inspiratory pressure was increased every 5 cmH2O, until reaching the maximum pressure of 40 cmH2O.

PCV

controlled ventilation and inspiratory pressure was increased every 5 cmH2O until the maximum pressure was 40 cmH2O. The inspiratory time was gradually increased until the inspiratory flow reached the baseline. Concomitantly, the respiratory rate was decreased to allow the expiratory flow also to reach the baseline, to avoid self-PEEP.

PCV+Tins
PSVOTHER

ventilatory mode with pressure support, with progressive increases of 5 cmH2O at inspiratory pressure, until reaching Pmax of 40 cmH2O. The expiratory sensitivity was adjusted by 25% for all patients.

PSV

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pulmonary infection
  • Mechanically ventilated for more than 96 hours through pressure-assisted ventilation (PSV) or pressure-controlled ventilation (PCV)
  • Static compliance between 30 and 70 mL/cmH2O
  • PEEP between 5 and 8 cmH2O.

You may not qualify if:

  • Hemodynamic instability
  • Non-drained pleural effusion or pneumothorax
  • Intracranial hypertension
  • Bronchospasm
  • Adult respiratory distress syndrome (ARDS)
  • Decompensated congestive heart failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Luciano M Chicayban

Campos dos Goytacazes, Rio de Janeiro, 28015150, Brazil

Location

MeSH Terms

Conditions

Respiratory Tract InfectionsPneumonia, Ventilator-Associated

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract DiseasesHealthcare-Associated PneumoniaCross InfectionPneumoniaLung DiseasesIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • LUCIANO M CHICAYBAN, MSc

    Brazilian Institute of Higher Education of Censa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: In order to perform both interventions, the patients were placed in dorsal decubitus with a head elevated at 45 ° and submitted to closed tracheal aspiration, according to the recommendations of the American Association for Respiratory Care. In addition, the bacteriological filter was changed, the cuff pressure was increased and the presence of leaks in the mechanical fan circuits was verified. All patients underwent five hyperinflation maneuvers, the order being determined by randomization. Controlled volume ventilation (VCV) at a constant flow rate of 20 Lpm (VCV-20) and 40 Lpm (VCV-40), controlled pressure ventilation (VCV-40) was performed for 2 minutes at 10 minute intervals. PCV), pressure-controlled ventilation associated with inspiratory time adjustment (PCV + Tins) and pressure-supported ventilation (PSV). PEEP and FiO2 were maintained throughout the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 6, 2018

First Posted

August 15, 2018

Study Start

March 18, 2017

Primary Completion

September 30, 2017

Study Completion

May 23, 2018

Last Updated

August 15, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations